GILEAD SCIENCES, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
GILEAD SCIENCES, INC. (GILD) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $979.00 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2026-05-07
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $979.00M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $2.94B.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $1.99B.
- 2025-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $1.91B.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2026-03-31 | $979.00M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.94B 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.99B 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.91B 10-Q · filed 2025-08-07 |
| 2023-12-31 | $1.15B 10-K · filed 2024-02-23 |
| 2023-09-30 | $1.15B 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.31B 10-Q · filed 2023-08-04 |
| 2023-03-31 | $1.31B 10-Q · filed 2023-05-03 |
| 2022-12-31 | $1.24B 10-K · filed 2023-02-22 |
| 2022-09-30 | $1.27B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.31B 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.40B 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.29B 10-K · filed 2022-02-23 |
| 2021-09-30 | $1.07B 10-Q · filed 2021-11-03 |
| 2021-06-30 | $814.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $562.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $490.00M 10-K · filed 2021-02-25 |
| 2020-09-30 | $1.99B 10-Q · filed 2020-11-04 |
| 2020-06-30 | $2.21B 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.51B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.47B 10-K · filed 2020-02-25 |
| 2019-09-30 | $2.17B 10-Q · filed 2019-11-05 |
| 2019-06-30 | $3.02B 10-Q · filed 2019-08-06 |
| 2019-03-31 | $2.17B 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.36B 10-K · filed 2019-02-26 |
| 2018-09-30 | $2.30B 10-Q · filed 2018-11-06 |
| 2018-06-30 | $5.65B 10-Q · filed 2018-08-06 |
| 2018-03-31 | $8.00B 10-Q · filed 2018-05-09 |
| 2017-12-31 | $11.05B 10-K · filed 2018-02-27 |
| 2016-12-31 | $19.76B 10-K · filed 2017-02-27 |
| 2015-12-31 | $11.39B 10-K · filed 2016-02-24 |
| 2015-06-30 | $6.00B 10-Q · filed 2015-08-05 |
| 2015-03-31 | $3.17B 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.58B 10-K · filed 2015-02-25 |
| 2014-09-30 | $1.37B 10-Q · filed 2014-11-05 |
| 2014-06-30 | $775.05M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $384.74M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $433.51M 10-K · filed 2014-02-25 |
| 2013-09-30 | $653.84M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $671.06M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $664.06M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $685.95M 10-K · filed 2013-02-27 |
| 2012-09-30 | $929.20M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $521.92M 10-Q · filed 2012-08-01 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-04 |
| 2011-12-31 | $8.25M 10-K · filed 2013-02-27 |
| 2011-09-30 | $3.09B 10-Q · filed 2011-11-04 |
| 2011-06-30 | $3.09B 10-Q · filed 2011-08-05 |
| 2011-03-31 | $3.20B 10-Q · filed 2011-05-09 |
| 2010-12-31 | $3.04B 10-K · filed 2012-02-23 |
| 2010-09-30 | $2.66B 10-Q · filed 2010-11-08 |
| 2010-06-30 | $2.04B 10-Q · filed 2010-08-09 |
| 2009-12-31 | $1.90B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |